Flow analysis is a broad term that refers to several distinct techniques across medicine, laboratory science, and healthcare operations. The most common medical meaning is flow cytometry, a laboratory method that examines individual cells by passing them single-file through a laser beam. But “flow analysis” also applies to measuring chemicals in water samples, tracking how patients move through a hospital, and studying blood flow through the cardiovascular system. Which type matters to you depends on context, so here’s what each one involves and why it’s used.
Flow Cytometry: Analyzing Cells One at a Time
Flow cytometry is the form of flow analysis most people encounter in a medical setting. It works by suspending cells in fluid, then streaming them past a laser so each cell can be individually measured. The technology relies on three integrated systems: a fluidics system that uses pressurized saline to focus cells into a single-file line, an optical system with lasers and light detectors, and an electronics system that converts the light signals into digital data a computer can read.
When a cell passes through the laser, it scatters light in patterns that reveal its size and internal complexity. Cells can also be tagged with fluorescent markers that bind to specific proteins on their surface. A series of filters inside the instrument steers each color of fluorescent light to the right detector, allowing the machine to identify multiple markers on the same cell simultaneously. Traditional instruments handle around a dozen markers at once. Newer spectral flow cytometers capture a continuous light spectrum from each cell, enabling finer distinctions between similar-looking markers. A related platform called mass cytometry replaces fluorescent tags with metal isotopes, which can measure up to 42 characteristics per cell with virtually no signal overlap between channels.
How Flow Cytometry Diagnoses Blood Cancers
One of the most important clinical uses of flow cytometry is diagnosing leukemias and lymphomas. The technique identifies specific proteins on the surface of blood cells, and the pattern of those proteins reveals whether cells are normal, immature, or cancerous.
In B-cell leukemia/lymphoma, flow cytometry detects markers like CD19, CD79a, and CD22, which identify the cells as belonging to the B-cell lineage. Cancerous B cells also show signs of immaturity: low levels of a protein called CD45, little to no CD20 (a marker of mature B cells), and the presence of stem cell markers that healthy mature cells don’t carry. T-cell leukemia/lymphoma shows a parallel but distinct profile, with markers like CD3, CD5, CD7, and CD2 confirming the T-cell identity, along with its own immaturity signatures.
These protein fingerprints help doctors distinguish between cancer types that may look identical under a microscope, which directly affects treatment decisions.
Immune Monitoring With CD4 and CD8 Counts
Flow cytometry is also the standard method for counting immune cell subsets, particularly CD4 and CD8 T cells. In a healthy adult, CD4 counts typically range from 500 to 1,200 cells per cubic millimeter of blood, while CD8 counts range from 150 to 1,000. The ratio of CD4 to CD8 cells is normally greater than 1.0. Tracking these numbers over time is essential for managing HIV and monitoring patients with immune deficiencies or those receiving immunosuppressive therapies.
Making Sense of the Data: Gating
Raw flow cytometry data is a cloud of thousands or millions of individual cell measurements. To make it useful, analysts use a process called gating, which is essentially drawing boundaries around cell populations of interest on a digital plot. The first gate typically separates intact cells from debris and air bubbles based on size and complexity. A second gate isolates single cells from clumps. A third removes dead cells using a viability stain. From there, additional gates identify specific populations based on their marker profiles.
Setting these boundaries accurately requires controls. The most common are called fluorescence-minus-one controls, where a sample is stained with every fluorescent marker except one. This shows the background signal for that missing marker, giving a clear cutoff between cells that genuinely carry the marker and those that don’t. Without proper controls, results can misclassify cells and lead to incorrect conclusions.
Flow Injection Analysis: Measuring Chemicals in Water
Outside of cell biology, flow analysis also refers to flow injection analysis (FIA), an automated technique for measuring chemical concentrations in liquid samples. A small volume of sample is injected into a continuously flowing stream of reagent. As the sample and reagent mix, a chemical reaction produces a measurable signal, typically a color change, fluorescence, or electrical current, that a detector reads.
FIA is widely used in environmental monitoring. It can detect heavy metals like mercury, lead, cadmium, and chromium in river water, lake water, and tap water. It also measures nutrients like nitrate, nitrite, and phosphate in seawater, and identifies organic pollutants including pesticides, phenolic compounds, and surfactants in groundwater and drinking water. Because determinations are rapid, FIA systems can serve as early-warning monitors for drinking water quality, flagging contamination in near real time. A major trend in the field is miniaturization, integrating all components of the measuring setup into a single compact instrument.
Patient Flow Analysis in Hospitals
In healthcare operations, flow analysis means mapping how patients move through a clinical visit, from check-in to checkout, to find delays and inefficiencies. The key metrics are cycle time (total time a patient spends in the system), waiting time (time spent not receiving care), and rooming time (time from being placed in a room to being seen). Bottlenecks are points where patients pile up because a step takes longer than the steps feeding into it.
A study of radiation oncology consultation visits at one center tracked 556 patient visits using real-time electronic medical record data. After implementing recommendations from a patient flow analysis, overall median cycle time dropped 21%, from 91 minutes to 72 minutes. Cumulative waiting time fell 64%, from 45 minutes to 16 minutes. Waiting room time specifically went from 14 minutes to 5 minutes, and the wait for a physician dropped from 20 minutes to 6 minutes. These are the kinds of concrete improvements that flow analysis can produce when a clinic systematically examines its own processes.
Hemodynamic Flow Analysis
In cardiovascular medicine, flow analysis refers to studying how blood moves through vessels and the heart. Under normal conditions, blood moves in smooth, parallel layers, a pattern called laminar flow. When a vessel narrows (from plaque buildup, for example) or blood velocity increases, the flow becomes turbulent, with chaotic swirling patterns. Turbulent flow creates the rushing sounds that doctors hear through a stethoscope during a blood pressure reading or when evaluating a heart murmur. The transition between laminar and turbulent flow is driven by shear stress, the friction between flowing blood and the vessel wall. Abnormal shear stress patterns are linked to damage of the vessel lining and progression of cardiovascular disease. Imaging techniques like Doppler ultrasound and computational fluid dynamics modeling allow clinicians and researchers to visualize these flow patterns and assess vascular health.